US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Ascopiave (0DME) 銘柄情報

Ascopiave (0DME)

3.5325

0.00

(0.00%)

終了 6月17日 12:30AM

Ascopiave (0DME) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

3.5325

( - )

買値

3.445

売値

3.62

出来高

0.00

0.00 日の範囲 0.00

3.5325 52 週間の範囲 3.5325

時価総額

前日終値

3.5325

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

124,432 €

発行済株式数

216,437,856

配当利回り

0.16 (5.28%)

PER

7.78

1 株当たり利益 (EPS)

0.39

歳入

260.31M

純利益

85.03M

Ascopiave S.p.A. engages in the distribution of natural gas in Italy. It operates through Gas Distribution, Renewable Energy, and Other segments. The company holds concessions and direct assignments for the management of gas distribution in various municipalities; and provides services to users thro... Ascopiave S.p.A. engages in the distribution of natural gas in Italy. It operates through Gas Distribution, Renewable Energy, and Other segments. The company holds concessions and direct assignments for the management of gas distribution in various municipalities; and provides services to users through a distribution network, as well as to catchment area. It also involved in the renewable energy and integrated water service sector; heat management and cogeneration activities; and production of energy from renewable sources through the management of hydroelectric, photovoltaic, and wind power plants. The company was founded in 1956 and is headquartered in Pieve di Soligo, Italy. Ascopiave S.p.A. is a subsidiary of Asco Holding SpA. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.gruppoascopiave.it

本社

Pieve Di Soligo, Italy

設立

2026

Ascopiave is listed in the sector of the ロンドン証券取引所 with ticker 0DME. The last closing price for Ascopiave was 3.53 €. Over the last year, Ascopiave shares have traded in a share price range of 3.5325 € to 3.5325 €.

Ascopiave currently has 216,437,856 shares in issue. The market capitalisation of Ascopiave is 764.57 € million. Ascopiave has a price to earnings ratio (PE ratio) of 7.78.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	3.5325	3.5325	3.5325	639	3.5325	DE
52	0	0	3.5325	3.5325	3.5325	281	3.5325	DE
156	0	0	3.5325	3.5325	3.5325	454	3.5325	DE
260	0	0	3.5325	3.5325	3.5325	931	3.5325	DE

0DME - Frequently Asked Questions (FAQ)

What is the current Ascopiave share price?

The current share price of Ascopiave is 3.5325 €

How many Ascopiave shares are in issue?

Ascopiave has 216,437,856 shares in issue

What is the market cap of Ascopiave?

The market capitalisation of Ascopiave is EUR 764.57M

What is the 1 year trading range for Ascopiave share price?

Ascopiave has traded in the range of 3.5325 € to 3.5325 € during the past year

What is the PE ratio of Ascopiave?

The price to earnings ratio of Ascopiave is 7.78

What is the cash to sales ratio of Ascopiave?

The cash to sales ratio of Ascopiave is 2.53

What is the registered address of Ascopiave?

The registered address for Ascopiave is Via Verizzo, 1030, Pieve di Soligo, Treviso, 31053

What is the Ascopiave website address?

The website address for Ascopiave is www.gruppoascopiave.it

Termite7

Termite7 1分前

Soon isn't the word......

US Market News

US Market News 8分前

Guardian Metal Resources PLC Announces Acquisition of Lincoln Estates & Water RightsJune 17, 2026 2:00 AM
ACCESS NewswireLONDON, UK / ACCESS Newswire / June 17, 2026 / Guardian Metal Res

DutchInvest

DutchInvest 12分前

Summary- LWLG has developed EO polymer, BEOL and SOH modulator device technology- EO polymer material and encapsulation achieved Telcordia reliability performance at thin filmand device level. Additional reliability studies underway for various reference devices- 200 and 400Gb/s devices designed and

tootalljones

tootalljones 18分前

I see that I have 161 followers. As we all know here on this erudite board of elderlies, I deserve no followers whatsoever. ......but I do need some new teeth. yep, my dentist told me that I need new choppers. .......so I want this buyout for 16 bucks to come through, and then I can get the chopp

MasterBlastr

MasterBlastr 20分前

Only thing I'm worried about is what do I do when my wallet is so fat I can't close it. Oh wait I have an idea.

https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcScVGQpebCFkwMdergI3prtoa19XfhB4lvLaeyONi53rw&s=10

US Market News

US Market News 23分前

Nextpower Announces Expansion of Solar Product Portfolio for International MarketJune 17, 2026 2:00 AM
Business Wire New two-in-portrait (2P) tracker system and innovative integrated foundation solution address comprehensive range of site and land-use requireme

Ammarmalhas

Ammarmalhas 31分前

At 67 and invested for 10+ years and still holding I must think of; Had I invested this money in an AI share this year I would have tripled my money!! Are we correct in holding on!? What are we really waiting for!? I may be losing faith!

ORCA

I SAW THE NEWS ON $VPLM AFTER MARKET.
I CHECKED OUT THE FIRM THEY BROUGHT IN.
THEY ARE BRINGING IN THE BIG GUNS.AGAINST READ BOLD.I AM INCREASING MY TARGETS AFTER THIS NEWS.
FROM .025 HIGH TO .15 WITHIN 2 YEARS.THE STOCK IS SHIFTING TO A POSITIVE OUT LOOK.IMO.
LAST COU

Steady_T

Steady_T 42分前

And yet your entire post is a personal attack. How strange.Clearly not as you wouldn't understand a shady OTC biotech penny stock with little chance of success. You clearly have too much money tied up in this and seem to only respond with personal attacks. Not pretty, hope it's not your retirement m

MineInvestor01

MineInvestor01 44分前

The June 17 announcement was encouraging to read. DTREF’s magnetic and radiometric surveys in Music Valley confirm it is clearly worthwhile to do more exploration. The elevated thorium signatures and the monazite and xenotime mineralization are positives. More needs to be done, of course. That is al

ducci1

ducci1 47分前

Pivot Calcs: SPX Pivot 7527---R1 7547---S1 7491---SPY Pivot 751---R1 753---S1 748----ES Pivot 7606---R1 7634---S1 7577----VIX Pivot 16.20---R1 16,64---S1 15.97---15 min Bull//Bear R/Line 17.42!------!!LOL!!

MartinLutherKing

MartinLutherKing 1時間前

SEii Is Going Nuclear ☢️ With News.. Stay Tuned for life changing news$$$$

Achilles deFlandres

Achilles deFlandres 1時間前

IMHO, one major event explicitly impacting the timeline of f2 relisting; IT IS NOT IN THE TOP TEN PRIORITIES, MAYBE NOT TOP 100. And, events all take precedence.

nshi2

nshi2 1時間前

Translating the OLED Playbook to EOP
Reliability Challenge Modern OLED Solution Electro-Optic Polymer Equivalent
Moisture/Oxygen Ingress (Damp Heat) Dyadic Thin-Film Encapsulation (TFE / ALD) Atomic layer deposition (ALD) directly over the EOP slot
waveguide; passes 85/85 dam

CelestialSage6

CelestialSage6 1時間前

It is unfortunate news that Halozyme eventually gave up the mdase patent.

https://www.thebionews.net/news/articleView.html?idxno=25562

MartinLutherKing

MartinLutherKing 1時間前

Keep lying to yourself, we all know your looking for em cheapies.. The pedlar short flippers are out of ammo.. Your out of luck, got to slap the ask

Watts Watt

Watts Watt 1時間前

Smart investors would take advantage of sharp price drops and scoop up cheap shares manically. To get Jack, you got to be nimble...nary tremble. Frick stay?

shajandr

shajandr 1時間前

IMO, Australia and similarly situated oil consumers should treat this 60-day opening as temporary and they ought to buy and ship as much oil as they can gett their hands on in the next 60 days. These types of oil importers should be willing to pay top Dollar to obtain as much oil as they can handle

Stockman1010101

Stockman1010101 1時間前

FNMA & FMCC Stock prices targets:
- 1st Target: $9, met 2026
- 2nd Target: $12, met 2026
- 3rd Target: $16, met 2026
- 4th Target: $20, met 2026
-5th Target: $30, met 2027
- 6th Target: $50, met 2027
- 7th Target: $70, met 2027
- 8th Target: $1

Steady_T

Steady_T 1時間前

I wondered when you would resort to personal attacks.

Your arguments are weak and do not stand up to scrutiny.
So time to switch to plan B, attack the poster.

Steady_T

Steady_T 1時間前

No I don't and neither do you. That is not the issue. NICE may not decide that the cost that NWBO is willing to accept is worth the result.

That is an unknown. If NICE looks at the data and decides that the survival benefit is not worth the cost then the treatment will not be reimbur

Cruz Battery Metals

VanEck Vectors Morningst...

Exchange Traded Commodit...

ISE Mexican Peso FX Spot

Westpac Banking

Hanesbrands Inc Dl 01

Evolution Gaming (PK)

Royal Bank of Scotland

Metasphere Labs

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。